| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.42e-08 | 18 | 108 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.75e-07 | 28 | 108 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.60e-06 | 37 | 108 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.15e-06 | 70 | 108 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.58e-06 | 118 | 108 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MCM8 MYO10 YTHDC2 RFC1 DNAH7 NLRP3 DNAH12 EIF4A2 DNAH17 RECQL4 DNAI2 DNAH6 DYNC1H1 | 2.74e-05 | 614 | 108 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 2.90e-05 | 2 | 108 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 2.90e-05 | 2 | 108 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MCM8 YTHDC2 RFC1 DNAH7 NLRP3 DNAH12 EIF4A2 RECQL4 DNAH6 DYNC1H1 | 1.40e-04 | 441 | 108 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 MCM8 YTHDC2 RFC1 DNAH7 DIRAS3 NLRP3 RGS20 DNAH12 EIF4A2 RECQL4 RGS17 DNAH6 DYNC1H1 | 1.71e-04 | 839 | 108 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 MCM8 YTHDC2 RFC1 DNAH7 DIRAS3 NLRP3 RGS20 DNAH12 EIF4A2 RECQL4 RGS17 DNAH6 DYNC1H1 | 1.73e-04 | 840 | 108 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 MCM8 YTHDC2 RFC1 DNAH7 DIRAS3 NLRP3 RGS20 DNAH12 EIF4A2 RECQL4 RGS17 DNAH6 DYNC1H1 | 1.73e-04 | 840 | 108 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MCM8 YTHDC2 RFC1 DNAH7 DIRAS3 NLRP3 RGS20 DNAH12 EIF4A2 RECQL4 RGS17 DNAH6 DYNC1H1 | 2.82e-04 | 775 | 108 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 2.87e-04 | 5 | 108 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 RAPGEF6 TRIO NET1 PREX2 DENND4C RGS20 RGS17 ARHGAP25 SGSM3 | 4.27e-04 | 507 | 108 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 RAPGEF6 TRIO NET1 PREX2 DENND4C RGS20 RGS17 ARHGAP25 SGSM3 | 4.27e-04 | 507 | 108 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | serotonin receptor activity | 4.29e-04 | 6 | 108 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 5.98e-04 | 7 | 108 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 5.98e-04 | 7 | 108 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.22e-03 | 86 | 108 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.27e-03 | 10 | 108 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.27e-03 | 10 | 108 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.27e-03 | 10 | 108 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.33e-03 | 88 | 108 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 1.85e-03 | 12 | 108 | 2 | GO:0045503 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.17e-03 | 13 | 108 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.91e-03 | 15 | 108 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 3.31e-03 | 16 | 108 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 3.31e-03 | 16 | 108 | 2 | GO:0050543 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 2.11e-06 | 41 | 106 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 5.74e-05 | 15 | 106 | 3 | GO:0051791 | |
| GeneOntologyBiologicalProcess | cilium movement | 6.11e-05 | 261 | 106 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 7.82e-05 | 3 | 106 | 2 | GO:0048252 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.55e-09 | 25 | 107 | 6 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 1.10e-08 | 54 | 107 | 7 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.52e-05 | 10 | 107 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.93e-05 | 161 | 107 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | chromocenter | 1.01e-04 | 18 | 107 | 3 | GO:0010369 | |
| GeneOntologyCellularComponent | dynein axonemal particle | 1.40e-04 | 20 | 107 | 3 | GO:0120293 | |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 2.57e-04 | 5 | 107 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 2.57e-04 | 5 | 107 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.31e-04 | 360 | 107 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 5.80e-04 | 32 | 107 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | axoneme | 6.91e-04 | 207 | 107 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.09e-04 | 208 | 107 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.23e-03 | 317 | 107 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.66e-03 | 12 | 107 | 2 | GO:0036157 | |
| Domain | ChSh | 1.73e-07 | 3 | 105 | 3 | SM00300 | |
| Domain | Chromo_shadow_dom | 1.73e-07 | 3 | 105 | 3 | IPR008251 | |
| Domain | Chromo_shadow | 1.73e-07 | 3 | 105 | 3 | PF01393 | |
| Domain | Dynein_heavy_chain_D4_dom | 9.04e-07 | 14 | 105 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 9.04e-07 | 14 | 105 | 4 | IPR013602 | |
| Domain | DHC_N2 | 9.04e-07 | 14 | 105 | 4 | PF08393 | |
| Domain | AAA_8 | 9.04e-07 | 14 | 105 | 4 | PF12780 | |
| Domain | DHC_fam | 1.23e-06 | 15 | 105 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.23e-06 | 15 | 105 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 1.23e-06 | 15 | 105 | 4 | PF03028 | |
| Domain | Chromo_dom_subgr | 2.01e-05 | 10 | 105 | 3 | IPR017984 | |
| Domain | Dynein_HC_stalk | 6.01e-05 | 14 | 105 | 3 | IPR024743 | |
| Domain | MT | 6.01e-05 | 14 | 105 | 3 | PF12777 | |
| Domain | ATPase_dyneun-rel_AAA | 6.01e-05 | 14 | 105 | 3 | IPR011704 | |
| Domain | AAA_5 | 6.01e-05 | 14 | 105 | 3 | PF07728 | |
| Domain | Chromodomain_CS | 1.32e-04 | 18 | 105 | 3 | IPR023779 | |
| Domain | AAA+_ATPase | 1.63e-04 | 144 | 105 | 6 | IPR003593 | |
| Domain | AAA | 1.63e-04 | 144 | 105 | 6 | SM00382 | |
| Domain | P-loop_NTPase | MCM8 MYO10 YTHDC2 RFC1 NMRK2 DNAH7 DIRAS3 NLRP3 TRANK1 DNAH12 EIF4A2 RECQL4 DNAH6 DYNC1H1 | 2.80e-04 | 848 | 105 | 14 | IPR027417 |
| Domain | Chromo_domain | 3.21e-04 | 24 | 105 | 3 | IPR023780 | |
| Domain | Chromo | 4.09e-04 | 26 | 105 | 3 | PF00385 | |
| Domain | CHROMO_1 | 5.11e-04 | 28 | 105 | 3 | PS00598 | |
| Domain | CHROMO_2 | 5.11e-04 | 28 | 105 | 3 | PS50013 | |
| Domain | Chromodomain-like | 7.61e-04 | 32 | 105 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 8.33e-04 | 33 | 105 | 3 | IPR000953 | |
| Domain | CHROMO | 8.33e-04 | 33 | 105 | 3 | SM00298 | |
| Domain | KRAB | 9.35e-04 | 358 | 105 | 8 | PS50805 | |
| Domain | KRAB | 9.35e-04 | 358 | 105 | 8 | PF01352 | |
| Domain | - | MCM8 YTHDC2 RFC1 NMRK2 DNAH7 DIRAS3 TRANK1 DNAH12 EIF4A2 RECQL4 DNAH6 DYNC1H1 | 9.82e-04 | 746 | 105 | 12 | 3.40.50.300 |
| Domain | KRAB | 1.13e-03 | 369 | 105 | 8 | SM00349 | |
| Domain | KRAB | 1.15e-03 | 370 | 105 | 8 | IPR001909 | |
| Domain | GDS_CDC24_CS | 1.36e-03 | 39 | 105 | 3 | IPR001331 | |
| Domain | CENP-B_N | 1.37e-03 | 10 | 105 | 2 | PF04218 | |
| Domain | WD40_repeat_dom | 1.45e-03 | 297 | 105 | 7 | IPR017986 | |
| Domain | HTH_Psq | 1.99e-03 | 12 | 105 | 2 | IPR007889 | |
| Domain | HTH_PSQ | 1.99e-03 | 12 | 105 | 2 | PS50960 | |
| Domain | HTH_CENPB | 2.35e-03 | 13 | 105 | 2 | PS51253 | |
| Domain | HTH_Tnp_Tc5 | 2.35e-03 | 13 | 105 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 2.35e-03 | 13 | 105 | 2 | IPR006600 | |
| Domain | - | 2.75e-03 | 333 | 105 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.85e-03 | 335 | 105 | 7 | IPR015943 | |
| Domain | WD40 | 3.44e-03 | 259 | 105 | 6 | PF00400 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.57e-03 | 16 | 105 | 2 | IPR001846 | |
| Domain | VWFD | 3.57e-03 | 16 | 105 | 2 | PS51233 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | PF00094 | |
| Domain | WD40 | 4.07e-03 | 268 | 105 | 6 | SM00320 | |
| Domain | WD40_repeat | 4.37e-03 | 272 | 105 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 4.85e-03 | 278 | 105 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.94e-03 | 279 | 105 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.94e-03 | 279 | 105 | 6 | PS50294 | |
| Domain | DH_1 | 5.37e-03 | 63 | 105 | 3 | PS00741 | |
| Domain | CRAL_TRIO | 6.13e-03 | 21 | 105 | 2 | PF00650 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.46e-07 | 27 | 86 | 5 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.03e-06 | 43 | 86 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.58e-06 | 45 | 86 | 5 | M47670 | |
| Pubmed | 5.92e-10 | 14 | 111 | 5 | 9373155 | ||
| Pubmed | Stage-specific expression of polycomb group genes in human bone marrow cells. | 3.16e-08 | 3 | 111 | 3 | 9454751 | |
| Pubmed | Dynamic associations of heterochromatin protein 1 with the nuclear envelope. | 3.16e-08 | 3 | 111 | 3 | 11101528 | |
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 3.16e-08 | 3 | 111 | 3 | 28270609 | |
| Pubmed | Maintenance of stable heterochromatin domains by dynamic HP1 binding. | 3.16e-08 | 3 | 111 | 3 | 12560555 | |
| Pubmed | Gene regulation by human orthologs of Drosophila heterochromatin protein 1. | 3.16e-08 | 3 | 111 | 3 | 12054505 | |
| Pubmed | Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. | 3.16e-08 | 3 | 111 | 3 | 10460410 | |
| Pubmed | HP1gamma function is required for male germ cell survival and spermatogenesis. | 3.16e-08 | 3 | 111 | 3 | 20423503 | |
| Pubmed | Differential contribution of HP1 proteins to DNA end resection and homology-directed repair. | 3.16e-08 | 3 | 111 | 3 | 23287531 | |
| Pubmed | Pericentromeric heterochromatin domains are maintained without accumulation of HP1. | 3.16e-08 | 3 | 111 | 3 | 17314413 | |
| Pubmed | HP1 proteins compact DNA into mechanically and positionally stable phase separated domains. | 3.16e-08 | 3 | 111 | 3 | 33661100 | |
| Pubmed | N-terminal phosphorylation of HP1{alpha} promotes its chromatin binding. | 3.16e-08 | 3 | 111 | 3 | 21245376 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17855382 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 17381543 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10330177 | ||
| Pubmed | The mouse HP1 proteins are essential for preventing liver tumorigenesis. | 1.26e-07 | 4 | 111 | 3 | 32020053 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10747027 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 15342492 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9636146 | ||
| Pubmed | E3 ubiquitin ligase HECW2 mediates the proteasomal degradation of HP1 isoforms. | 1.26e-07 | 4 | 111 | 3 | 30208514 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 31961023 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11793364 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 11959914 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 23077635 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 10562550 | ||
| Pubmed | Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. | 3.15e-07 | 5 | 111 | 3 | 17962312 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 16127177 | ||
| Pubmed | Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway. | 3.15e-07 | 5 | 111 | 3 | 23542155 | |
| Pubmed | An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions. | 3.15e-07 | 5 | 111 | 3 | 28059589 | |
| Pubmed | DNA methyltransferase 3b preferentially associates with condensed chromatin. | 6.28e-07 | 6 | 111 | 3 | 20923784 | |
| Pubmed | A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. | 6.28e-07 | 6 | 111 | 3 | 15145825 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 22318730 | ||
| Pubmed | Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. | 6.28e-07 | 6 | 111 | 3 | 15200951 | |
| Pubmed | Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage. | 6.28e-07 | 6 | 111 | 3 | 25634209 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 12414990 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 22615490 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 1978328 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 12242305 | ||
| Pubmed | Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones. | 1.75e-06 | 8 | 111 | 3 | 8098006 | |
| Pubmed | Recognition and specificity determinants of the human cbx chromodomains. | 1.75e-06 | 8 | 111 | 3 | 21047797 | |
| Pubmed | Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. | 1.75e-06 | 8 | 111 | 3 | 11336697 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 15120635 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 23645681 | ||
| Pubmed | Cdc42 and mDia3 regulate microtubule attachment to kinetochores. | 3.74e-06 | 10 | 111 | 3 | 15085137 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 23748610 | ||
| Pubmed | ARHGAP32 KTN1 MUC16 ZNF227 RFC1 DNAH7 FER1L6 NCOR2 C1GALT1C1 DNAH12 AP1B1 | 6.55e-06 | 638 | 111 | 11 | 31182584 | |
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 19486527 | ||
| Pubmed | 7.20e-06 | 83 | 111 | 5 | 20562864 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 21778144 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 15322135 | ||
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 8978696 | ||
| Pubmed | 9.21e-06 | 538 | 111 | 10 | 28524877 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15611369 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23928294 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17891782 | ||
| Pubmed | Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. | 1.01e-05 | 2 | 111 | 2 | 11242054 | |
| Pubmed | Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss. | 1.01e-05 | 2 | 111 | 2 | 24400116 | |
| Pubmed | MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice. | 1.01e-05 | 2 | 111 | 2 | 19427893 | |
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 1.01e-05 | 2 | 111 | 2 | 23641057 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 28912346 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 24413902 | ||
| Pubmed | Regulation of an inducible promoter by an HP1beta-HP1gamma switch. | 1.01e-05 | 2 | 111 | 2 | 18239689 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 8031839 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12151339 | ||
| Pubmed | SET-domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. | 1.01e-05 | 2 | 111 | 2 | 23797873 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10860550 | ||
| Pubmed | Functional domain analysis of human HP1 isoforms in Drosophila. | 1.01e-05 | 2 | 111 | 2 | 17575412 | |
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 1.01e-05 | 2 | 111 | 2 | 11320253 | |
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 1.01e-05 | 2 | 111 | 2 | 12464262 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 34139556 | ||
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 1.01e-05 | 2 | 111 | 2 | 15066132 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19561096 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10097111 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23825080 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 16691295 | ||
| Pubmed | Heterochromatin protein 1 expression is reduced in human thyroid malignancy. | 1.01e-05 | 2 | 111 | 2 | 24840329 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 3829886 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23251473 | ||
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 1.01e-05 | 2 | 111 | 2 | 29277328 | |
| Pubmed | A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants. | 1.01e-05 | 2 | 111 | 2 | 1708124 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21820496 | ||
| Pubmed | Heterochromatin protein 1 binds to nucleosomes and DNA in vitro. | 1.01e-05 | 2 | 111 | 2 | 10882726 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33675822 | ||
| Pubmed | Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. | 1.01e-05 | 2 | 111 | 2 | 14765118 | |
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 1.01e-05 | 2 | 111 | 2 | 20943934 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 2766933 | ||
| Pubmed | Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38. | 1.01e-05 | 2 | 111 | 2 | 24596247 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15157181 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19066844 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17112342 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22647716 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26081624 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20695923 | ||
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 1.01e-05 | 2 | 111 | 2 | 30088983 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 8287692 | ||
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 1.01e-05 | 2 | 111 | 2 | 19208908 | |
| Pubmed | 1.07e-05 | 90 | 111 | 5 | 28978906 | ||
| Pubmed | Interactions of MCP1 with components of the replication machinery in mammalian cells. | 1.12e-05 | 14 | 111 | 3 | 21383955 | |
| Pubmed | 1.12e-05 | 14 | 111 | 3 | 20231385 | ||
| Pubmed | 1.40e-05 | 15 | 111 | 3 | 21163256 | ||
| Interaction | ZNF280D interactions | 7.35e-06 | 24 | 107 | 4 | int:ZNF280D | |
| Cytoband | 22q11.21 | 7.89e-06 | 111 | 111 | 5 | 22q11.21 | |
| Cytoband | 8p23.1 | 5.52e-04 | 154 | 111 | 4 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 5.64e-04 | 419 | 111 | 6 | chr22q11 | |
| Cytoband | 1p31 | 1.18e-03 | 21 | 111 | 2 | 1p31 | |
| Cytoband | 3q27.1 | 1.95e-03 | 27 | 111 | 2 | 3q27.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p31 | 2.20e-03 | 224 | 111 | 4 | chr1p31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.57e-03 | 234 | 111 | 4 | chr8p23 | |
| Cytoband | 15q21.3 | 3.27e-03 | 35 | 111 | 2 | 15q21.3 | |
| Cytoband | 1p33 | 3.27e-03 | 35 | 111 | 2 | 1p33 | |
| GeneFamily | Dyneins, axonemal | 1.28e-08 | 17 | 86 | 5 | 536 | |
| GeneFamily | Chromobox family | 5.72e-06 | 8 | 86 | 3 | 976 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 2.22e-04 | 5 | 86 | 2 | 172 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 4.62e-04 | 7 | 86 | 2 | 653 | |
| GeneFamily | WD repeat domain containing | 1.56e-03 | 262 | 86 | 6 | 362 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 1.69e-03 | 13 | 86 | 2 | 533 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.83e-03 | 66 | 86 | 3 | 722 | |
| GeneFamily | CD molecules|Mucins | 4.43e-03 | 21 | 86 | 2 | 648 | |
| GeneFamily | Regulators of G-protein signaling | 4.43e-03 | 21 | 86 | 2 | 720 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 4.40e-09 | 151 | 111 | 8 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.38e-08 | 196 | 111 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.03e-07 | 190 | 111 | 7 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.03e-07 | 190 | 111 | 7 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-07 | 191 | 111 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-07 | 191 | 111 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-07 | 191 | 111 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 5.39e-07 | 192 | 111 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.39e-07 | 192 | 111 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.59e-07 | 193 | 111 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-07 | 195 | 111 | 7 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.99e-07 | 195 | 111 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-07 | 195 | 111 | 7 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.99e-07 | 195 | 111 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.20e-07 | 196 | 111 | 7 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.09e-07 | 200 | 111 | 7 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-06 | 169 | 111 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.66e-06 | 178 | 111 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.66e-06 | 178 | 111 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-06 | 180 | 111 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.22e-06 | 181 | 111 | 6 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-06 | 181 | 111 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.42e-06 | 182 | 111 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.42e-06 | 182 | 111 | 6 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.42e-06 | 182 | 111 | 6 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.42e-06 | 182 | 111 | 6 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.84e-06 | 184 | 111 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.05e-06 | 185 | 111 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.05e-06 | 185 | 111 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.27e-06 | 186 | 111 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.27e-06 | 186 | 111 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 7.50e-06 | 187 | 111 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.50e-06 | 187 | 111 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 7.50e-06 | 187 | 111 | 6 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 7.73e-06 | 188 | 111 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.73e-06 | 188 | 111 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 7.73e-06 | 188 | 111 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.73e-06 | 188 | 111 | 6 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.73e-06 | 188 | 111 | 6 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.73e-06 | 188 | 111 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.73e-06 | 188 | 111 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.97e-06 | 189 | 111 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.97e-06 | 189 | 111 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 7.97e-06 | 189 | 111 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.97e-06 | 189 | 111 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.97e-06 | 189 | 111 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.97e-06 | 189 | 111 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-06 | 190 | 111 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.72e-06 | 192 | 111 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.72e-06 | 192 | 111 | 6 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 8.72e-06 | 192 | 111 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.72e-06 | 192 | 111 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.72e-06 | 192 | 111 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.98e-06 | 193 | 111 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 8.98e-06 | 193 | 111 | 6 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.98e-06 | 193 | 111 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.25e-06 | 194 | 111 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-06 | 194 | 111 | 6 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.25e-06 | 194 | 111 | 6 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-06 | 194 | 111 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.25e-06 | 194 | 111 | 6 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-06 | 194 | 111 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 9.52e-06 | 195 | 111 | 6 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 9.52e-06 | 195 | 111 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-06 | 195 | 111 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-06 | 195 | 111 | 6 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 9.52e-06 | 195 | 111 | 6 | 3441381759cd00d125752401dc99b78be1c78f88 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.52e-06 | 195 | 111 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-06 | 195 | 111 | 6 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.52e-06 | 195 | 111 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-06 | 196 | 111 | 6 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.80e-06 | 196 | 111 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-06 | 196 | 111 | 6 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.80e-06 | 196 | 111 | 6 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-06 | 196 | 111 | 6 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.80e-06 | 196 | 111 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 197 | 111 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-05 | 197 | 111 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 197 | 111 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 197 | 111 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-05 | 197 | 111 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 197 | 111 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-05 | 197 | 111 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-05 | 197 | 111 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-05 | 198 | 111 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.04e-05 | 198 | 111 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | distal-Epithelial-Ciliated-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 198 | 111 | 6 | d30d6c6a0a78b7571318b5b2a0186df96dd0f5a9 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-05 | 199 | 111 | 6 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 200 | 111 | 6 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 200 | 111 | 6 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Biopsy_IPF-Epithelial-Differentiating_Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.10e-05 | 200 | 111 | 6 | 8dfce65e417d6dcacb871d93d1539cdf807002fe | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 200 | 111 | 6 | cf71c3f6281650940f3ade04ea62be3f340bfc68 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 200 | 111 | 6 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.43e-05 | 123 | 111 | 5 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-05 | 144 | 111 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 4.34e-05 | 155 | 111 | 5 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 1.42e-07 | 14 | 104 | 4 | DOID:0060413 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 3.96e-05 | 19 | 104 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | CWF19L2 PPP2R2D YTHDC2 XKR6 ZNF227 DNAJC6 LEPR NLRP3 TRANK1 DNAH17 SCN4A POLR1B RGS17 ANAPC4 | 8.66e-05 | 1206 | 104 | 14 | EFO_0004458 |
| Disease | restrictive cardiomyopathy (is_implicated_in) | 1.83e-04 | 6 | 104 | 2 | DOID:397 (is_implicated_in) | |
| Disease | X-14939 measurement | 1.83e-04 | 6 | 104 | 2 | EFO_0800747 | |
| Disease | alkaline phosphatase measurement | CES1 XKR6 LEPR NLRP3 TRANK1 RECQL4 MYMK UNC13C ARHGAP25 UGT2B11 UTRN ANAPC4 | 2.43e-04 | 1015 | 104 | 12 | EFO_0004533 |
| Disease | eye color | 2.95e-04 | 90 | 104 | 4 | EFO_0003949 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 6.63e-04 | 11 | 104 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Ischemic stroke, fibrinogen measurement | 9.77e-04 | 55 | 104 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, factor VII measurement | 1.14e-03 | 58 | 104 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | diet measurement | MGAM TRIO PPP2R2D HTR3E XKR6 LEPR TRANK1 CBX5 RGS17 UNC13C ANAPC4 | 1.19e-03 | 1049 | 104 | 11 | EFO_0008111 |
| Disease | Inborn Errors of Metabolism | 1.62e-03 | 17 | 104 | 2 | C0025521 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.73e-03 | 67 | 104 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 2.02e-03 | 19 | 104 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, coronary artery disease | 2.19e-03 | 154 | 104 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Malignant tumor of colon | 2.46e-03 | 159 | 104 | 4 | C0007102 | |
| Disease | hemoglobin A1 measurement | 2.48e-03 | 520 | 104 | 7 | EFO_0007629 | |
| Disease | epilepsy (implicated_via_orthology) | 2.69e-03 | 163 | 104 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | progression free survival, ovarian serous carcinoma | 2.71e-03 | 22 | 104 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | apolipoprotein A 1 measurement | 3.10e-03 | 848 | 104 | 9 | EFO_0004614 | |
| Disease | primary biliary cholangitis (is_marker_for) | 3.50e-03 | 25 | 104 | 2 | DOID:12236 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEEEIRLSKMVMKFW | 486 | P23141 | |
| WEEILMQMDSRLTKF | 276 | Q9UJX5 | |
| MMKDIIPASSWASEE | 1 | A4D250 | |
| LMFLMKWKDSDEADL | 136 | Q13185 | |
| LMFLMKWKDTDEADL | 136 | P45973 | |
| TVDSMLLDMEKEVWE | 186 | A5X5Y0 | |
| LMADSVRVMLDKWEE | 161 | Q02928 | |
| MMTRDYLSVKVWDLN | 306 | Q66LE6 | |
| TVDSMLLGMDKEVWE | 186 | Q8WXA8 | |
| VEDGKMDRQMFLATW | 836 | Q10567 | |
| SSLSSLEKLMMDWNE | 1196 | Q5TGY3 | |
| TRMDGTLDIWDFMFE | 426 | Q9GZS0 | |
| KVFESINMDTNDMWL | 106 | Q96EU7 | |
| LADIMKDKDNFWMTR | 361 | P61160 | |
| EEVLSWSQNFDKMMK | 76 | Q9UGC6 | |
| DWSDQIDVTKMSVIM | 231 | O14718 | |
| WSEMLDITMKESLTT | 156 | Q7Z628 | |
| MTMKELLDKLCWTES | 146 | P27338 | |
| WITEMMNSVSEDTIK | 3881 | Q8WXI7 | |
| MWSEQEKETFREKFM | 431 | Q9Y618 | |
| CANKEDTWKFLDMMQ | 146 | Q9BZ81 | |
| ENMLKETLEYKMSWF | 731 | Q92805 | |
| MKESAARVLQEAWMF | 311 | O15554 | |
| MDWQSIKIQELMSDD | 286 | Q9UJA3 | |
| WDQLKKSIIGMMEFS | 1531 | O43451 | |
| MWNREDALMLELDTK | 146 | Q02817 | |
| RDEWMTVDFMSVKTV | 151 | Q2TBE0 | |
| LEKAMNTMIGTWEDI | 826 | Q6ZR08 | |
| EQMLDMWIKEEVSSA | 1906 | Q9HD67 | |
| MWDVAEELKAMLVFA | 106 | P42785 | |
| REDISIMIKFWTAMF | 1401 | P42356 | |
| DISIMIKFWTAMFSD | 146 | Q8N8J0 | |
| NWEAMEALASTEKML | 1036 | Q86UP2 | |
| DISVDTSWKNKDEMM | 921 | P48357 | |
| WCTDVKSMEMLVEHQ | 356 | Q9UNM6 | |
| MMDSPFLELWQSKAV | 1 | O94886 | |
| EMLVWMSKDSSYLQE | 126 | Q5TGP6 | |
| SWDLEDMEKYRMQSI | 1741 | A7KAX9 | |
| VVSMLVASWSVDDLM | 66 | Q86SP6 | |
| VMFELAWMLSKDLND | 201 | O75419 | |
| SWMLAMEELIKTFTD | 3606 | Q9C0G6 | |
| EKVLKALDSTWSMME | 1411 | Q9UFH2 | |
| MEAYWTALALNMSEE | 736 | Q7Z3S7 | |
| LMADSVRVMLDKWEE | 161 | Q5TCH4 | |
| LEKAMEKMITEWDAV | 901 | Q8WXX0 | |
| KMIFMELNDAWSEFE | 891 | O75061 | |
| SMLGDVLSIMDKEEW | 216 | Q9H3Q1 | |
| ELMFLMKWKNSDEAD | 131 | P83916 | |
| EADFSWQKKMTQLEM | 546 | Q5VZ89 | |
| TLYMDTWRKDSVVML | 166 | P27544 | |
| MDFSESEKFMVLLWK | 1 | A6NIL9 | |
| WIKMFVLDEADEMLS | 176 | Q14240 | |
| EEEMLWESIMRVLSK | 16 | Q86Y33 | |
| AMWETLSVTGVDKEM | 81 | Q8WXU2 | |
| DKIIMEDKGIMSTAW | 306 | Q5VTH9 | |
| MVWFSEDVLSTDMIF | 2361 | Q14204 | |
| EELTQMVSTMSDGWK | 166 | Q9NXV2 | |
| SMTKQLGDFWTRMEE | 1031 | Q13751 | |
| MEMLWNKTFEAEELS | 111 | A0A1B0GTZ2 | |
| MAKVSELYDVTWEEM | 1 | Q15006 | |
| SMDKTMILWAPDEES | 311 | Q6IA86 | |
| MEWNCAFMEISAKTD | 171 | O95661 | |
| NFLSMKEWVSMVLDT | 991 | Q5VW36 | |
| VWICMELMDTSLDKF | 136 | P46734 | |
| WICMELMDTSLDKFY | 126 | P52564 | |
| TLMIDFNGEEKAWAM | 56 | Q96P20 | |
| FKQWDVLESLDMEAM | 51 | Q9NPI5 | |
| WSNMLEKMADFLEES | 596 | Q2WGJ9 | |
| MSMREEIAVWTNLTE | 116 | P78337 | |
| KSWEMFEEMITTAEE | 336 | P49591 | |
| TVIEKWMDGVKDFLM | 1026 | P46939 | |
| LSFTEQSWMDLKGMF | 536 | Q9UGT4 | |
| ETDEEKFQMMSLQWE | 1121 | Q8TEU7 | |
| SILFKWMTMESEKIS | 171 | Q8WUY3 | |
| WMDIMYAAVDSREKE | 1246 | P35499 | |
| MKEDFENIMEISSWG | 1031 | P35251 | |
| EENMLFWMACEELKK | 286 | O76081 | |
| EFDMVKLVDSMGWEL | 986 | O94761 | |
| LLLFLEEEDAFWMMS | 211 | Q96HU1 | |
| DISIMIKFWTAMFSD | 146 | A4QPH2 | |
| ANSTKEEVEMNWDMV | 201 | Q8N5C6 | |
| VMESMEQLLSLWLED | 86 | B2RD01 | |
| SDDMTLKIWSMKQEV | 431 | O60907 | |
| TDFCMSKWEEILFNM | 406 | Q5GH73 | |
| FTQEEWAMMDTSKRK | 16 | Q6ZN79 | |
| ISAEIMWTLFALDMK | 1626 | Q8NB66 | |
| SKMTIKMNESDIWFE | 296 | Q13596 | |
| FLMDAQRKWFLEMES | 461 | Q96MW7 | |
| EMEKISVQATWMAYD | 31 | A1L190 | |
| LMASSQAEMEEWVKF | 131 | P42331 | |
| TFWVDGDMDLSISMT | 116 | Q3KNW5 | |
| LKLGMEQDTWVMISE | 366 | Q70Z35 | |
| FTQEEWAMMDTSKRK | 16 | A8MWA4 | |
| MSDMKKWDQFYSEVL | 226 | O75310 | |
| FTQEEWAMMDTSKRK | 16 | A8MUZ8 | |
| SSRAMYAVDLMLKWD | 576 | Q14166 | |
| KEEKFWMMETATQRE | 61 | Q9UK10 | |
| FTQEEWDMMDTSKRK | 16 | P0CI00 | |
| FTQEEWDMMDTSKRK | 16 | P0CH99 | |
| QMLKTIDAMDTWEDL | 811 | Q9H6S0 | |
| EKFWMMETATQREGN | 61 | Q9UIE0 | |
| EAEEKLWMMETETQR | 76 | Q86WZ6 | |
| KSFLEANLEWMQEEM | 156 | Q8NHP8 | |
| MKALWDEFNQLGTEM | 116 | O43435 | |
| DNMTWEIECTSEMLK | 786 | O15050 | |
| YDMEDAMIVNKASWE | 751 | Q9H9Y6 | |
| FIEDTEMMIGAKRWI | 506 | Q9UN76 | |
| EKLNEWTSADMMELY | 271 | P48595 | |
| KDVAVEFTQEEWMML | 46 | A8MT65 | |
| MDGIMVTWKDNFDSF | 2781 | O75962 | |
| DFNWRMKEVLVSSML | 281 | Q9GZU3 | |
| LSMWVSLMALADFDE | 76 | A6NI61 |